Skip to main content
Professionisti
Competenze
Articoli
Sedi
Our Firm
News
Eventi
Careers
search menu
Cerca
italiano
العربية
Deutsch
English
English (United Kingdom)
español
עברית
日本語
한국어
Nederlands
polski
português
中文
Cerca
submit search
{{typeahead}}
2006
Articolo pubblicato
Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and In Vivo Antiinflammatory Activity
Competenze
Life Sciences & Medical Technology
Sedi
Boston
Condividi
John Buchanan co-authored an article titled "Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and In Vivo Antiinflammatory Activity" in the
Journal of Medicinal Chemistry
.
Potrebbe interessarti anche:
July 25, 2024 - July 26, 2024
Event
ACI's 11th Annual Summit for Women Leaders in Life Sciences Law
Boston, United States
May 29, 2024 - May 30, 2024
Event
Yale Innovation Summit 2024
New Haven
March 28, 2024, 8:00 AM - 4:00 PM ET
Event
2024 Medtech Impact Symposium
Everett